Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

  • Showing results for a modified search because your search retrieved no results.
1.

Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence.

Desplats P, Dumaop W, Cronin P, Gianella S, Woods S, Letendre S, Smith D, Masliah E, Grant I.

PLoS One. 2014 Jul 23;9(7):e102555. doi: 10.1371/journal.pone.0102555. eCollection 2014.

2.

Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat.

Liu X, Chang L, Vigorito M, Kass M, Li H, Chang SL.

J Neuroimmune Pharmacol. 2009 Sep;4(3):309-16. doi: 10.1007/s11481-009-9160-8. Epub 2009 May 15.

PMID:
19444617
3.

Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system.

Hoefer MM, Sanchez AB, Maung R, de Rozieres CM, Catalan IC, Dowling CC, Thaney VE, PiƱa-Crespo J, Zhang D, Roberts AJ, Kaul M.

Exp Neurol. 2015 Jan;263:221-34. doi: 10.1016/j.expneurol.2014.09.010. Epub 2014 Sep 20.

4.

Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Flora G, Lee YW, Nath A, Hennig B, Maragos W, Toborek M.

Exp Neurol. 2003 Jan;179(1):60-70.

PMID:
12504868
5.

Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings.

Gupta S, Bousman CA, Chana G, Cherner M, Heaton RK, Deutsch R, Ellis RJ, Grant I, Everall IP.

J Neurovirol. 2011 Jun;17(3):239-47. doi: 10.1007/s13365-011-0028-3. Epub 2011 Apr 14.

6.

Functional interactions of HIV-infection and methamphetamine dependence during motor programming.

Archibald SL, Jacobson MW, Fennema-Notestine C, Ogasawara M, Woods SP, Letendre S, Grant I, Jernigan TL.

Psychiatry Res. 2012 Apr 30;202(1):46-52. doi: 10.1016/j.pscychresns.2012.03.006. Epub 2012 May 17.

7.

Epigenetic upregulation of alpha-synuclein in the rats exposed to methamphetamine.

Jiang W, Li J, Zhang Z, Wang H, Wang Z.

Eur J Pharmacol. 2014 Dec 15;745:243-8. doi: 10.1016/j.ejphar.2014.10.043. Epub 2014 Nov 5.

PMID:
25445041
8.

HIV and chronic methamphetamine dependence affect cerebral blood flow.

Ances BM, Vaida F, Cherner M, Yeh MJ, Liang CL, Gardner C, Grant I, Ellis RJ, Buxton RB; HIV Neurobehavioral Research Center (HNRC) Group.

J Neuroimmune Pharmacol. 2011 Sep;6(3):409-19. doi: 10.1007/s11481-011-9270-y. Epub 2011 Mar 24.

9.

Patterns of selective neuronal damage in methamphetamine-user AIDS patients.

Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E; HIV Neurobehavioral Research Center Group.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):467-74.

PMID:
14657756
10.

Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.

Cadet JL, Krasnova IN.

Neurotox Res. 2007 Oct;12(3):181-204. Review.

PMID:
17967742
11.

Methamphetamine and HIV-Tat alter murine cardiac DNA methylation and gene expression.

Koczor CA, Fields E, Jedrzejczak MJ, Jiao Z, Ludaway T, Russ R, Shang J, Torres RA, Lewis W.

Toxicol Appl Pharmacol. 2015 Nov 1;288(3):409-19. doi: 10.1016/j.taap.2015.08.012. Epub 2015 Aug 22.

PMID:
26307267
12.

Epigenetic modification of FOXP3 in patients with chronic HIV infection.

Abdel-Hameed EA, Ji H, Sherman KE, Shata MT.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):19-26. doi: 10.1097/QAI.0b013e3182a1bca4.

13.

Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis.

Mahajan SD, Hu Z, Reynolds JL, Aalinkeel R, Schwartz SA, Nair MP.

Mol Diagn Ther. 2006;10(4):257-69.

PMID:
16884330
14.

Dynamic indices of methamphetamine dependence and HIV infection predict fluctuations in affective distress: a five-year longitudinal analysis.

Montoya JL, Umlauf A, Abramson I, Badiee J, Woods SP, Atkinson JH, Grant I, Moore DJ; TMARC Group.

J Affect Disord. 2013 Nov;151(2):728-37. doi: 10.1016/j.jad.2013.07.036. Epub 2013 Aug 16.

15.

Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.

Moore DJ, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, Grant I; Hnrc Group And The Tmarc Group.

AIDS Care. 2012;24(12):1504-13. doi: 10.1080/09540121.2012.672718. Epub 2012 Apr 24.

16.

Methamphetamine use is associated with childhood sexual abuse and HIV sexual risk behaviors among patrons of alcohol-serving venues in Cape Town, South Africa.

Meade CS, Watt MH, Sikkema KJ, Deng LX, Ranby KW, Skinner D, Pieterse D, Kalichmann SC.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):232-9. doi: 10.1016/j.drugalcdep.2012.05.024. Epub 2012 Jun 19.

17.

Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.

Rajendran G, Shanmuganandam K, Bendre A, Muzumdar D, Goel A, Shiras A.

J Neurooncol. 2011 Sep;104(2):483-94. doi: 10.1007/s11060-010-0520-2. Epub 2011 Jan 13. Erratum in: J Neurooncol. 2011 Sep;104(2):495. Mujumdar, Dattatreya [corrected to Muzumdar, Dattatraya].

PMID:
21229291
18.

Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells.

Lee YW, Hennig B, Yao J, Toborek M.

J Neurosci Res. 2001 Nov 15;66(4):583-91.

PMID:
11746378
19.
20.

Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype.

Watson CJ, Collier P, Tea I, Neary R, Watson JA, Robinson C, Phelan D, Ledwidge MT, McDonald KM, McCann A, Sharaf O, Baugh JA.

Hum Mol Genet. 2014 Apr 15;23(8):2176-88. doi: 10.1093/hmg/ddt614. Epub 2013 Dec 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk